These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23534124)
21. Ultrasound, electromyography, and balloon guidance for injecting botulinum toxin for cricopharyngeal achalasia: A case report. Chen JM; Chen YJ; Ni J; Wang ZY Medicine (Baltimore); 2021 Mar; 100(11):e24909. PubMed ID: 33725963 [TBL] [Abstract][Full Text] [Related]
22. Pharyngeal Motility Before and After Thyroarytenoid Muscle Botulinum Toxin Injection. Mororó WC; Herbella FA; de Oliveira KVG; De Biase NG Dysphagia; 2020 Oct; 35(5):806-813. PubMed ID: 31863177 [TBL] [Abstract][Full Text] [Related]
23. Management of upper esophageal sphincter disorders: indications and complications of myotomy. Kelly JH Am J Med; 2000 Mar; 108 Suppl 4a():43S-46S. PubMed ID: 10718451 [TBL] [Abstract][Full Text] [Related]
24. Comparison studies of ultrasound-guided botulinum toxin injection and balloon catheter dilatation in the treatment of neurogenic cricopharyngeal muscle dysfunction. Luan S; Wu SL; Xiao LJ; Yang HY; Liao MX; Wang SL; Fan SN; Ma C NeuroRehabilitation; 2021; 49(4):629-639. PubMed ID: 34806624 [TBL] [Abstract][Full Text] [Related]
25. Retrograde cricopharyngeal dysfunction and treatment with botulinum toxin: a systematic review. Jönsson CH; Plaschke CC Eur Arch Otorhinolaryngol; 2024 Sep; 281(9):4495-4505. PubMed ID: 38564007 [TBL] [Abstract][Full Text] [Related]
28. Endoscopic cricopharyngeal myotomy for management of cricopharyngeal achalasia (CA) in an 18-month-old child. Chun R; Sitton M; Tipnis NA; Arvedson JC; Rao A; Dranove J; Brown DJ Laryngoscope; 2013 Mar; 123(3):797-800. PubMed ID: 22991054 [TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin A injection using ultrasound combined with balloon guidance for the treatment of cricopharyngeal dysphagia: analysis of 21 cases. Zhu L; Chen J; Shao X; Pu X; Zheng J; Zhang J; Wu X; Wu D Scand J Gastroenterol; 2022 Jul; 57(7):884-890. PubMed ID: 35213271 [TBL] [Abstract][Full Text] [Related]
30. Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. Storr M; Born P; Frimberger E; Weigert N; Rösch T; Meining A; Classen M; Allescher HD BMC Gastroenterol; 2002 Aug; 2():19. PubMed ID: 12175425 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin injection for dysphagia: a blinded retrospective videofluoroscopic swallowing study analysis. Lee SY; Seo HG; Paik NJ Am J Phys Med Rehabil; 2009 Jun; 88(6):491-4. PubMed ID: 19325455 [TBL] [Abstract][Full Text] [Related]
32. Mano-videoendoscopic assessment in the evaluation of the pharyngeal contraction and upper esophageal sphincter function in dysphagic patients. Karaho T; Nakajima J; Satoh T; Kawahara K; Nakayama T; Kohno N Auris Nasus Larynx; 2017 Feb; 44(1):79-85. PubMed ID: 27595503 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Kim DY; Park CI; Ohn SH; Moon JY; Chang WH; Park SW Arch Phys Med Rehabil; 2006 Oct; 87(10):1346-51. PubMed ID: 17023244 [TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199 [TBL] [Abstract][Full Text] [Related]
35. Cricopharyngeal achalasia in children: surgical and medical treatment. Drendel M; Carmel E; Kerimis P; Wolf M; Finkelstein Y Isr Med Assoc J; 2013 Aug; 15(8):430-3. PubMed ID: 24079064 [TBL] [Abstract][Full Text] [Related]
36. Treatment for upper esophageal sphincter dysfunction in a patient with poststroke dysphagia: A case report. Wei P; Xu Y; Zhang Z; Zhang S; Lv Z Medicine (Baltimore); 2019 Mar; 98(13):e14988. PubMed ID: 30921211 [TBL] [Abstract][Full Text] [Related]
37. Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction. Jeong SH; Kim YJ; Kim YJ; Park KD; Kim EJ; Chung JW; Kwon KA; Kim KO; Park DK; Kim JH; Cho JH Scand J Gastroenterol; 2018; 53(10-11):1201-1205. PubMed ID: 30353754 [TBL] [Abstract][Full Text] [Related]
38. ALS dysphagia pathophysiology: differential botulinum toxin response. Restivo DA; Casabona A; Nicotra A; Zappia M; Elia M; Romano MC; Alfonsi E; Marchese-Ragona R Neurology; 2013 Feb; 80(7):616-20. PubMed ID: 23345638 [TBL] [Abstract][Full Text] [Related]
39. Case report: botulinum toxin in hypertensive lower esophageal sphincter: a manometric case study. Lacy BE; Zayat EN; Crowell MD Dysphagia; 2002; 17(1):75-80. PubMed ID: 11820389 [TBL] [Abstract][Full Text] [Related]
40. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]